Notably, even though MTAP IHC alone demonstrated a high sensitivity and specificity in detecting MTAP HD (96% and 100%, respectively), it showed a low sensitivity (73%) to discern CDKN2A HD in this PXA cohort, which is explained by the absence of MTAP HD on those cases. This evidence concerns the gene CDKN2A and Huntington disease.